Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
European Radiology|May 19, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programmeAndrew W Creamer, Carolyn Horst, Priyam Verghese, et al.
The European Respiratory Journal|July 27, 2022
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometrySophie Tisi, Jennifer L Dickson, Carolyn Horst, et al.
BMJ Open Respiratory Research|June 15, 2023
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohortSophie Tisi, Andrew W Creamer, Jennifer Dickson, et al.
The Lancet. Oncology|October 20, 2012
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trialSiow Ming Lee, Iftekhar Khan, Sunil Upadhyay, et al.
BMJ (Clinical Research Ed.)|May 25, 2026
UK National Screening Committee position statement on surrogate outcomes in cancer screening trialsSarah Batson, Allan Hackshaw, Anne Mackie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2022
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trialSiow Ming Lee, Madeleine Hewish, Samreen Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patientsMichael Paulussen, Alan W Craft, Ian Lewis, et al.
BMJ Open Respiratory Research|February 6, 2025
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening settingAmyn Bhamani, Evangelos Katsampouris, Fanta Bojang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
European Radiology|May 19, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programmeAndrew W Creamer, Carolyn Horst, Priyam Verghese, et al.
The European Respiratory Journal|July 27, 2022
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometrySophie Tisi, Jennifer L Dickson, Carolyn Horst, et al.
BMJ Open Respiratory Research|June 15, 2023
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohortSophie Tisi, Andrew W Creamer, Jennifer Dickson, et al.
The Lancet. Oncology|October 20, 2012
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trialSiow Ming Lee, Iftekhar Khan, Sunil Upadhyay, et al.
BMJ (Clinical Research Ed.)|May 25, 2026
UK National Screening Committee position statement on surrogate outcomes in cancer screening trialsSarah Batson, Allan Hackshaw, Anne Mackie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 26, 2022
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trialSiow Ming Lee, Madeleine Hewish, Samreen Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patientsMichael Paulussen, Alan W Craft, Ian Lewis, et al.
BMJ Open Respiratory Research|February 6, 2025
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening settingAmyn Bhamani, Evangelos Katsampouris, Fanta Bojang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
Pageof 17